AU2020292378A1 - Novel secreted antigens for diagnosis of active Babesia microti and Babesia duncani infection in humans and animals - Google Patents

Novel secreted antigens for diagnosis of active Babesia microti and Babesia duncani infection in humans and animals Download PDF

Info

Publication number
AU2020292378A1
AU2020292378A1 AU2020292378A AU2020292378A AU2020292378A1 AU 2020292378 A1 AU2020292378 A1 AU 2020292378A1 AU 2020292378 A AU2020292378 A AU 2020292378A AU 2020292378 A AU2020292378 A AU 2020292378A AU 2020292378 A1 AU2020292378 A1 AU 2020292378A1
Authority
AU
Australia
Prior art keywords
infection
babesia
subject
sample
microti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020292378A
Other languages
English (en)
Inventor
Choukri BEN MAMOUN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU2020292378A1 publication Critical patent/AU2020292378A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2020292378A 2019-06-12 2020-06-12 Novel secreted antigens for diagnosis of active Babesia microti and Babesia duncani infection in humans and animals Abandoned AU2020292378A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962860662P 2019-06-12 2019-06-12
US62/860,662 2019-06-12
US201962937645P 2019-11-19 2019-11-19
US62/937,645 2019-11-19
PCT/US2020/037500 WO2020252313A1 (en) 2019-06-12 2020-06-12 Novel secreted antigens for diagnosis of active babesia microti and babesia duncani infection in humans and animals

Publications (1)

Publication Number Publication Date
AU2020292378A1 true AU2020292378A1 (en) 2022-01-06

Family

ID=73781883

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020292378A Abandoned AU2020292378A1 (en) 2019-06-12 2020-06-12 Novel secreted antigens for diagnosis of active Babesia microti and Babesia duncani infection in humans and animals

Country Status (8)

Country Link
US (1) US20220236268A1 (https=)
EP (1) EP3983430A4 (https=)
JP (2) JP2022536679A (https=)
CN (1) CN114072419A (https=)
AU (1) AU2020292378A1 (https=)
BR (1) BR112021025089A2 (https=)
CA (1) CA3143027A1 (https=)
WO (1) WO2020252313A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220341928A1 (en) * 2021-04-23 2022-10-27 Id-Fish Technology, Inc. Diagnosis of babesia using babesia recombinant proteins
CN119462946B (zh) * 2024-10-21 2025-10-03 华中农业大学 抗邓肯巴贝斯虫ald蛋白的单克隆抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053016A2 (en) * 2001-01-05 2002-07-11 Corixa Corporation Compounds and methods for the diagnosis and treatment of babesia infection
US7704508B2 (en) * 2007-09-14 2010-04-27 New York Blood Center Babesia subtilisin
CN104845981B (zh) * 2015-05-25 2018-06-19 中国疾病预防控制中心寄生虫病预防控制所 田鼠巴贝虫Bm1524抗原及其应用
US20180372742A1 (en) * 2015-12-10 2018-12-27 Immport Therapeutics, Inc. Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test
CN108893476B (zh) * 2018-06-28 2022-07-05 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 田鼠巴贝虫2d97抗原蛋白及其应用

Also Published As

Publication number Publication date
JP2025186283A (ja) 2025-12-23
CA3143027A1 (en) 2020-12-17
EP3983430A4 (en) 2023-10-11
JP2022536679A (ja) 2022-08-18
EP3983430A1 (en) 2022-04-20
WO2020252313A1 (en) 2020-12-17
US20220236268A1 (en) 2022-07-28
BR112021025089A2 (pt) 2022-02-15
CN114072419A (zh) 2022-02-18

Similar Documents

Publication Publication Date Title
JP2025186283A (ja) ヒトおよび動物における活動性のバベシア・ミクロティ感染およびバベシア・ダンカニ感染を診断するための新規な分泌抗原
Winter et al. SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes
Li et al. Recombinant antigens for immunodiagnosis of cystic echinococcosis
HUP0200777A2 (en) Method of diagnosing transmissible spongiform encephalopathies
Bertuccini et al. Unveiling Cryptosporidium parvum sporozoite-derived extracellular vesicles: profiling, origin, and protein composition
AU2004219885A1 (en) Diagnostic and prognostic compounds and method
AU2021421855B2 (en) Virus-like particle comprising toxoplasma gondii protein and influenza virus protein, and diagnostic method using same
Zhou et al. Molecular identification and antigenic characterization of a merozoite surface antigen and a secreted antigen of Babesia canis (BcMSA1 and BcSA1)
JP2026034816A (ja) 潜伏形態のトキソプラズマ症についての新たな血清マーカー
US8268981B2 (en) Plasmodium malariae and plasmodium ovale genes and uses thereof
US8030471B2 (en) Plasmodium malariae and Plasmodium ovale genes and uses thereof
EP3686601B1 (en) Serological detection of plasmodium antibodies
Emiroğlu et al. First report of human ehrlichiosis in Turkey
CN103491979A (zh) 基于来自恶性疟原虫的红细胞前期抗原的疟疾疫苗
EP3667322A1 (en) Serological detection of plasmodium antibodies
JPWO2019107387A1 (ja) マラリア治療薬、マラリアの治療方法、マラリア治療用候補物質のスクリーニング方法、マラリア重症化マーカー、マラリアの重症化の危険度を試験する方法および試験試薬
US20120128680A1 (en) Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
Omorodion Identification of Immunodominant Antigen in Babesia microti Using Phage Display cDNA Technology
Singh DEVELOPMENT OF RECOMBINANT ANTIGEN BASED ELISA FOR SERODIAGNOSIS OF TOXOPLASMOSIS IN HUMANS AND ANIMALS

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted